These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
939 related articles for article (PubMed ID: 34855832)
21. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19. Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668 [TBL] [Abstract][Full Text] [Related]
22. Prognosis of COVID-19: Changes in laboratory parameters. Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944 [TBL] [Abstract][Full Text] [Related]
23. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159 [TBL] [Abstract][Full Text] [Related]
25. Cytokine storm in severe COVID-19 pneumonia. Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559 [TBL] [Abstract][Full Text] [Related]
26. Study on Laboratory Indicators Related to Lung Injury of Corona Virus Disease 2019. Zhang Y; Chen Q; Yao L; Chen J; Yu X Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491433 [TBL] [Abstract][Full Text] [Related]
27. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866 [TBL] [Abstract][Full Text] [Related]
28. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan. Hassan Shah SST; Naeem I; Wahid B Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879 [TBL] [Abstract][Full Text] [Related]
29. Clinical laboratory characteristics in patients with suspected COVID-19: One single-institution experience. Fei F; Smith JA; Cao L J Med Virol; 2021 Mar; 93(3):1665-1671. PubMed ID: 32946118 [TBL] [Abstract][Full Text] [Related]
31. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868 [TBL] [Abstract][Full Text] [Related]
32. The relationship between immature granulocyte count and mortality in ARDS Due to COVID-19. Alay GH; Tatlisuluoglu D; Bulut K; Fikri BI; Oztas A; Turan G Niger J Clin Pract; 2022 Aug; 25(8):1301-1307. PubMed ID: 35975379 [TBL] [Abstract][Full Text] [Related]
33. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients. Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055 [TBL] [Abstract][Full Text] [Related]
34. Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2. Snipelisky D; Johnson R; Prasad R; Lakhani B; Ellington J South Med J; 2020 Dec; 113(12):618-622. PubMed ID: 33263129 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients. Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303 [TBL] [Abstract][Full Text] [Related]
36. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome. Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145 [TBL] [Abstract][Full Text] [Related]
37. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971 [No Abstract] [Full Text] [Related]
38. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'. Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482 [TBL] [Abstract][Full Text] [Related]
39. Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response. Foulkes AS; Selvaggi C; Shinnick D; Lumish H; Kim E; Cao T; Thaweethai T; Qian J; Lu F; Yan J; Cheng D; He W; Clerkin KJ; Madhavan MV; Meigs JB; Triant VA; Lubitz SA; Gupta A; Bassett IV; Reilly MP J Clin Endocrinol Metab; 2022 Jan; 107(2):e698-e707. PubMed ID: 34473294 [TBL] [Abstract][Full Text] [Related]
40. COVID-19 associated pulmonary embolism: clinical, biochemical and CT imaging findings. Dumea E; Lazar M; Chitu-Tisu CE; Barbu EC; Ion DA Rom J Intern Med; 2024 Sep; 62(3):307-322. PubMed ID: 38641909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]